Xiaoxiao Wang
Family · Pasadena, CANPI 1346089141
Payments from drug & device makers
Across 183 payments — averaging $31.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- AstraZeneca$907
- Incyte Corporation$420
- Array Biopharma Inc$396
- Merck$232
- Astellas Pharma US Inc$226
- plus $3K from 32 others
What the payments were for
- Food & beverage$5,23690%
- Education$59510%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 24 | $1,006 |
| AstraZeneca | 30 | $907 |
| Incyte Corporation | 7 | $420 |
| Array Biopharma Inc | 18 | $396 |
| Merck | 8 | $232 |
| Astellas Pharma US Inc | 2 | $226 |
| AbbVie | 5 | $217 |
| Lilly USA, LLC | 10 | $211 |
| E.r. Squibb & Sons, L.L.C. | 10 | $208 |
| Sun Pharmaceutical Industries Inc. | 4 | $205 |
| Eisai Inc. | 7 | $164 |
| Ipsen Biopharmaceuticals, Inc | 5 | $145 |
| Boehringer Ingelheim | 5 | $134 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $127 |
| Tersera Therapeutics LLC | 3 | $110 |
| Seagen Inc. | 1 | $100 |
| Jazz Pharmaceuticals Inc. | 4 | $99 |
| Gilead | 3 | $90 |
| Sumitomo Pharma America, Inc. | 4 | $87 |
| Exelixis Inc. | 3 | $83 |
| Beigene USA, Inc. | 2 | $64 |
| Agios Pharmaceuticals, Inc. | 2 | $61 |
| EMD Serono, Inc. | 2 | $56 |
| Bayer | 2 | $55 |
| Genentech USA, Inc. | 2 | $53 |
| Novocure Inc. | 2 | $45 |
| Legend Biotech USA Inc. | 2 | $44 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $43 |
| Stemline Therapeutics Inc. | 1 | $34 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Bristol Myers Squibb | 1 | $28 |
| Pfizer | 1 | $25 |
| Rigel Pharmaceuticals, Inc. | 1 | $25 |
| Pharmaessentia USA Corporation | 1 | $25 |
| Kyowa Kirin, Inc. | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $22 |
| Amgen | 1 | $18 |
| ADC Therapeutics America, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,831 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 11 | $113 |
Paid to pharmacies, not to this prescriber.
Other family in Pasadena
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.